[Organoleptic evaluation of a diabetes-specific oral nutritional supplement with extra virgin olive oil in patients at nutritional risk and type 2 diabetes mellitus: Double-blind, randomized, crossover and multicenter clinical trial (DIACARE)].

What Was Tested

This randomized controlled trial looks at Copper (Supplement).

Objetive: to compare the sensory acceptability of a DSF with respect to a standard oral nutritional supplement (STF) in patients at risk of malnutrition with type 2 diabetes mellitus.

Why It Was Studied

Introduction: oral nutritional supplements specific for diabetes (DSF) usually have a composition that favors their palatability and simultaneous glycemic and metabolic control.

Method: randomized, double-blind, crossover, multicenter, controlled, double-blind clinical trial.

How the Study Was Run

The researchers set it up as a randomized, double-blind, crossover and multicenter study.

Because people in this Copper (Supplement) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

As a double-blind Copper (Supplement) study, the assignments were hidden from both participants and investigators until the end.

In the crossover set-up each of the participants took both Copper (Supplement) and the comparison in turn, acting as their own control.

Running at several centres spread the Copper (Supplement) study over different clinics and patient groups.

Odor, taste and perceived texture of a DSF and a STD were evaluated using a scale of 1 to 4.

What Was Measured

The subject headings attached to it are Diabetes Mellitus, Type 2, Dietary Supplements, Malnutrition, Olive Oil and Sensation.

Author keywords: Diabetes mellitus tipo 2. Desnutrición relacionada con la enfermedad. Suplemento específico para diabetes. AOVE. Sensorial.

What This Means in Plain Language

The paper is a randomized, double-blind and crossover study of Copper (Supplement).

The publication is from 2023 (Nutricion hospitalaria), a journal based in Spain.

More context: the Copper (Supplement) compound page, all human trials.